vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and CBAK Energy Technology, Inc. (CBAT). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $58.8M, roughly 1.4× CBAK Energy Technology, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -12.5%, a 19.4% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 117.4%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
BLLN vs CBAT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $58.8M |
| Net Profit | $5.7M | $-7.4M |
| Gross Margin | 69.9% | 7.3% |
| Operating Margin | 11.5% | -13.6% |
| Net Margin | 6.8% | -12.5% |
| Revenue YoY | 117.4% | 131.8% |
| Net Profit YoY | 138.3% | -63.6% |
| EPS (diluted) | $0.10 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $58.8M | ||
| Q3 25 | $83.5M | $60.9M | ||
| Q2 25 | — | $40.5M | ||
| Q1 25 | — | $34.9M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | $38.4M | $44.6M | ||
| Q2 24 | — | $47.8M | ||
| Q1 24 | — | $58.8M |
| Q4 25 | — | $-7.4M | ||
| Q3 25 | $5.7M | $2.7M | ||
| Q2 25 | — | $-3.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-4.5M | ||
| Q3 24 | $-14.9M | $17.6K | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $9.8M |
| Q4 25 | — | 7.3% | ||
| Q3 25 | 69.9% | 8.0% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | 52.6% | 15.6% | ||
| Q2 24 | — | 26.6% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | 11.5% | -6.6% | ||
| Q2 25 | — | -8.7% | ||
| Q1 25 | — | -8.2% | ||
| Q4 24 | — | -26.0% | ||
| Q3 24 | -32.9% | -1.9% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 17.4% |
| Q4 25 | — | -12.5% | ||
| Q3 25 | 6.8% | 4.4% | ||
| Q2 25 | — | -7.6% | ||
| Q1 25 | — | -4.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | -38.8% | 0.0% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 16.7% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $0.10 | $0.03 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.02 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-1.47 | $0.00 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $8.3M |
| Total DebtLower is stronger | $55.0M | $4.1M |
| Stockholders' EquityBook value | $-239.5M | $112.7M |
| Total Assets | $327.5M | $426.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.3M | ||
| Q3 25 | $195.2M | $10.5M | ||
| Q2 25 | — | $45.7M | ||
| Q1 25 | — | $9.6M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | — | $23.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $55.0M | $4.8M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $4.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $112.7M | ||
| Q3 25 | $-239.5M | $121.4M | ||
| Q2 25 | — | $118.2M | ||
| Q1 25 | — | $120.8M | ||
| Q4 24 | — | $121.7M | ||
| Q3 24 | $-242.9M | $131.2M | ||
| Q2 24 | — | $126.6M | ||
| Q1 24 | — | $120.9M |
| Q4 25 | — | $426.2M | ||
| Q3 25 | $327.5M | $363.9M | ||
| Q2 25 | — | $333.1M | ||
| Q1 25 | — | $311.5M | ||
| Q4 24 | — | $302.2M | ||
| Q3 24 | — | $293.5M | ||
| Q2 24 | — | $279.6M | ||
| Q1 24 | — | $286.5M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $29.8M |
| Free Cash FlowOCF − Capex | $6.5M | $16.1M |
| FCF MarginFCF / Revenue | 7.7% | 27.3% |
| Capex IntensityCapex / Revenue | 8.8% | 23.4% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.8M | ||
| Q3 25 | $13.8M | $14.6M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | — | $-9.6M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $19.7M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | — | $7.4M |
| Q4 25 | — | $16.1M | ||
| Q3 25 | $6.5M | $6.0M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-22.3M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $16.5M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $-454.0K |
| Q4 25 | — | 27.3% | ||
| Q3 25 | 7.7% | 9.9% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | -63.9% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | -0.8% |
| Q4 25 | — | 23.4% | ||
| Q3 25 | 8.8% | 14.1% | ||
| Q2 25 | — | 23.8% | ||
| Q1 25 | — | 36.3% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 13.4% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | 5.51× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1115.72× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
